Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Malignancy-associated hypercalcemia].

Shoji Oura1

  • 1Department of Thoracic and Cardiovascular Surgery, Wakayama Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 17, 2003
PubMed
Summary

Bisphosphonates effectively treat malignancy-associated hypercalcemia by inhibiting bone resorption. Combination therapy with calcitonin is beneficial for hypercalcemic crises, with zoledronate showing superior efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Florid Lobular Carcinoma In Situ (F-LCIS) Showing Predominantly Hypoechoic Masses With Obscured Margins and No Attenuated Posterior Echoes on Ultrasound: A Case Report.

Cureus·2026
Same author

Microlobulated Margins, Internal Punctate High Echoes, and Enhancing Internal Septation As Important Diagnostic Clues for Invasive Solid Papillary Carcinomas of the Breast: A Case Report.

Cureus·2026
Same author

Intraductal Components of Breast Cancer Spread to the Areola: A Case Report.

Cureus·2026
Same author

Cellulitis Occurring 21 Years After Radiofrequency Ablation for Breast Cancer: A Case Report.

Cureus·2026
Same author

Solid Papillary Carcinoma of the Breast With Invasion and Aggressive Characteristics: A Case Report.

Cureus·2026
Same author

Feasible Nipple Preservation Techniques for Breast Cancer With Suspected Ductal Spread to the Nipple Base on Imaging: A Case Report.

Cureus·2026

Area of Science:

  • Oncology
  • Pharmacology
  • Endocrinology

Context:

  • Malignancy-associated hypercalcemia (MAH) is a serious complication of cancer.
  • Bisphosphonates (BPs) are a cornerstone therapy for MAH.
  • Osteoclastic bone resorption is a key mechanism in MAH.

Purpose:

  • To review the efficacy and safety of bisphosphonates in treating malignancy-associated hypercalcemia.
  • To compare different bisphosphonates and combination therapies for MAH.
  • To highlight potential adverse effects of bisphosphonate therapy.

Summary:

  • Bisphosphonates inhibit osteoclastic bone resorption, effectively correcting MAH.
  • While potent, bisphosphonates act slower than calcitonin; combination therapy is recommended for hypercalcemic crisis.
  • Zoledronate demonstrates superior efficacy compared to pamidronate in MAH treatment.
  • Bisphosphonate therapy is generally safe, with rare serious adverse effects like acute renal failure.
  • Potential side effects include pyrexia and transient pain increase.

Impact:

  • Bisphosphonates represent a significant advancement in managing MAH.
  • Optimized bisphosphonate use, including combination therapy, can improve patient outcomes.
  • Understanding bisphosphonate mechanisms and side effects is crucial for effective clinical practice.

Related Experiment Videos